Literature DB >> 18414025

Anchorage-independent cytokinesis as part of oncogenic transformation?

Minna Thullberg1, Staffan Strömblad.   

Abstract

Cell anchorage to the extracellular matrix (ECM) controls the cell proliferation in all multicellular organisms and the abrogation of this control is an indicator of cellular transformation. In fact, two distinct periods of the cell cycle are subject to anchorage-dependent regulation. Firstly, anchorage exerts an extensive control of the G(1)-phase, a control that we found to be more rigorous than for example the control by growth factors. Secondly, anchorage regulates the progression through cytokinesis. In order to achieve anchorage-independent growth a cell must circumvent these controls. To this end, we recently found that oncogenic H-RasV12 can provide sufficient signals to overcome the anchorage-dependence for cytokinesis. Together with earlier findings on G(1)-phase control, this demonstrates that oncogenic signaling contributes to de-regulation of anchorage-dependence during both the G(1)-phase and the cytokinesis. This also suggests that de-regulated cytokinesis may be part of oncogenic transformation.

Mesh:

Year:  2008        PMID: 18414025     DOI: 10.4161/cc.7.8.5674

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  16 in total

1.  HDM2 promotes WIP1-mediated medulloblastoma growth.

Authors:  Meghan C Buss; Tracy-Ann Read; Matthew J Schniederjan; Khanjan Gandhi; Robert C Castellino
Journal:  Neuro Oncol       Date:  2012-02-29       Impact factor: 12.300

2.  Tetraploid cells produced by absence of substrate adhesion during cytokinesis are limited in their proliferation and enter senescence after DNA replication.

Authors:  Marco De Santis Puzzonia; Laetitia Gonzalez; Sonia Ascenzi; Enrico Cundari; Francesca Degrassi
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

Review 3.  The significance of PAK4 in signaling and clinicopathology: A review.

Authors:  Xinbo Yu; Changwei Huang; Jiyuan Liu; Xinyu Shi; Xiaodong Li
Journal:  Open Life Sci       Date:  2022-06-20       Impact factor: 1.311

4.  Application of a thermo-reversible gelation polymer, mebiol gel, for stem cell culture and regenerative medicine.

Authors:  K Kataoka; N Huh
Journal:  J Stem Cells Regen Med       Date:  2010-04-05

5.  Fibronectin assembly in the crypts of cytokinesis-blocked multilobular cells promotes anchorage-independent growth.

Authors:  Rajesh Kumar Gupta; Staffan Johansson
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

6.  Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice.

Authors:  E Buache; N Etique; F Alpy; I Stoll; M Muckensturm; B Reina-San-Martin; M P Chenard; C Tomasetto; M C Rio
Journal:  Oncogene       Date:  2011-02-28       Impact factor: 9.867

Review 7.  Stem cells, progenitor cells, and lineage decisions in the ovary.

Authors:  Katja Hummitzsch; Richard A Anderson; Dagmar Wilhelm; Ji Wu; Evelyn E Telfer; Darryl L Russell; Sarah A Robertson; Raymond J Rodgers
Journal:  Endocr Rev       Date:  2014-12-26       Impact factor: 19.871

8.  MTA2 promotes gastric cancer cells invasion and is transcriptionally regulated by Sp1.

Authors:  Chenfei Zhou; Jun Ji; Qu Cai; Min Shi; Xuehua Chen; Yingyan Yu; Bingya Liu; Zhenggang Zhu; Jun Zhang
Journal:  Mol Cancer       Date:  2013-09-08       Impact factor: 27.401

9.  PLK1 gene suppresses cell invasion of undifferentiated thyroid carcinoma through the inhibition of CD44v6, MMP-2 and MMP-9.

Authors:  Xing-Guang Zhang; Xiao-Feng Lu; Xiu-Ming Jiao; Bin Chen; Jin-Xiao Wu
Journal:  Exp Ther Med       Date:  2012-09-28       Impact factor: 2.447

10.  Up-regulation of Imp3 confers in vivo tumorigenicity on murine osteosarcoma cells.

Authors:  Arisa Ueki; Takatsune Shimizu; Kenta Masuda; Sayaka I Yamaguchi; Tomoki Ishikawa; Eiji Sugihara; Nobuyuki Onishi; Shinji Kuninaka; Keita Miyoshi; Akihiro Muto; Yoshiaki Toyama; Kouji Banno; Daisuke Aoki; Hideyuki Saya
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.